World Journal of Urology

, Volume 36, Issue 7, pp 1175–1176 | Cite as

Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis

  • Erdem Kisa
Letter to Editor


  1. 1.
    Ozden E, Bostanci Y, Yakupoglu KY et al (2009) Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74:119–123CrossRefPubMedGoogle Scholar
  2. 2.
    Dede G, Şencan İ, Dede O et al (2014) Our experience on developing urinary tract infections after transrectal prostate biopsy. Dicle Med J 41:108–112. CrossRefGoogle Scholar
  3. 3.
    Taylor S, Margolick J, Abughosh Z et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111:946–953CrossRefPubMedGoogle Scholar
  4. 4.
    Kisa E, Altug MU, Gurbuz OA et al (2017) Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors. Int Braz J Urol 43(6):1068–1074CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Taylor AK, Zembower TR, Nadler RB et al (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187:1275–1279CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Urology DepartmentTepecik Training and Research HospitalIzmirTurkey

Personalised recommendations